NASDAQ · Analyst Forecast

Utah Medical Products, Inc. (UTMD) Analyst Forecast

$73.52 NASDAQ: UTMD Market Cap $233.34M

Revenue and earnings estimates published by analysts covering Utah Medical Products, Inc. (UTMD), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Utah Medical Products, Inc., analysts forecast revenue rising from $61.52T in 2018 to $99.08T in 2023; the average estimate for 2023 earnings per share is $6.29; with published estimates ranging from $5.03 to $7.54; 19 analysts contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD millions)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

Year	Low	Average	High	Analysts
2018	$49.22T	$61.52T	$73.83T	16
2019	$54.14T	$67.67T	$81.21T	12
2020	$59.55T	$74.44T	$89.33T	19
2021	$65.51T	$81.88T	$98.26T	12
2022	$72.06T	$90.07T	$108.09T	13
2023	$79.26T	$99.08T	$118.90T	14

Earnings per share forecast

Year	Low	Average	High	Analysts
2018	$3.13	$3.90	$4.67	16
2019	$3.44	$4.29	$5.14	12
2020	$3.79	$4.73	$5.67	19
2021	$4.16	$5.20	$6.23	12
2022	$4.57	$5.71	$6.85	13
2023	$5.03	$6.29	$7.54	14

Utah Medical Products, Inc. (UTMD) forecast — frequently asked questions

What are analysts forecasting for Utah Medical Products, Inc.'s earnings?

The average analyst estimate for Utah Medical Products, Inc. (UTMD) earnings per share in 2023 is 6.29, with individual estimates between 5.03 and 7.54.

How much revenue is Utah Medical Products, Inc. expected to make?

Analysts forecast Utah Medical Products, Inc. (UTMD) revenue of $99.08T in 2023, based on 14 published estimates.

How many analysts cover UTMD?

19 analysts contribute estimates for Utah Medical Products, Inc. (UTMD). Thin coverage makes an average less reliable.

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks Nasdaq High ROE Stocks All stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.